Latest Share Chat

Shield Thera Share News (STX)

Shield Thera Information

Buy STX Shares
Add STX to Watchlist
Add STX to Alert

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.55

Bid: 1.50

Ask: 1.60

Change: -0.025 (-1.59%)

Spread: 0.10 (6.667%)

Open: 1.575

High: 1.575

Low: 1.55

Prev. Close: 1.575

Last checked at -

IN BRIEF: Shield Therapeutics changes reporting currency to US dollars

Wed, 06th Sep 2023 20:33

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Says it will change reporting currency to US dollars from pound sterling from 2023 results. Says the interim results for the first half of 2023 will include condensed and consolidated US dollar financial information for the period and full-year 2022.

Current stock price: 10.92 pence, up 1.6%

12-month change: down 14%

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

17 May 2021 15:04

TRADING UPDATES: Pelatro gets contracts; Futura raises GBP10 million

10 May 2021 15:01

EXECUTIVE CHANGES: Hansard Global hires new CEO; Argentex co-CEO back

29 Apr 2021 17:33

TRADING UPDATES: Keystone Law and Checkit post annual revenue growth

22 Apr 2021 16:10

UK earnings, trading statements calendar - next 7 days

26 Mar 2021 15:40

TRADING UPDATES: Contango in offtake talks for coking coal in Zimbabwe

22 Mar 2021 12:48

UPDATE: Shield Therapeutics hires finance chief to help US expansion

22 Mar 2021 11:22

Shield Therapeutics hires new finance chief to help US expansion

22 Mar 2021 08:18

Shield taps Hans-Peter Rudolf as its new finance chief

(Sharecast News) - Commercial-stage pharmaceuticals company Shield Therapeutics announced on Monday that Hans-Peter Rudolf was joining its senior executive team as chief financial officer, with immediate effect.

11 Mar 2021 16:11

UK shareholder meetings calendar - next 7 days

9 Mar 2021 15:56

Shield's Feraccru gets registration in Australia

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics said on Tuesday that Australia's Therapeutics Goods Administration (TGA) has registered 'Feraccru' in the country's Register of Therapeutic Goods, to treat iron deficiency with or without anaemia in adults.

9 Mar 2021 14:18

Latest Share Chat

Shield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

IN BRIEF: Shield Therapeutics changes reporting currency to US dollars

TRADING UPDATES: Pelatro gets contracts; Futura raises GBP10 million

EXECUTIVE CHANGES: Hansard Global hires new CEO; Argentex co-CEO back

TRADING UPDATES: Keystone Law and Checkit post annual revenue growth

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Contango in offtake talks for coking coal in Zimbabwe

UPDATE: Shield Therapeutics hires finance chief to help US expansion

Shield Therapeutics hires new finance chief to help US expansion

Shield taps Hans-Peter Rudolf as its new finance chief

UK shareholder meetings calendar - next 7 days

Shield's Feraccru gets registration in Australia

IN BRIEF: Shield Therapeutics says Feraccru approved in Australia

DIRECTOR DEALINGS: StanChart HR head sells shares; Nichols CEO buys

DIRECTOR DEALINGS: Man and Rio Tinto execs sell; IHG non-exec buys

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

AIM WINNERS & LOSERS: K3 Business Rises On Starcom Technologies Sale

Latest Share Chat

Shield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Shield Therapeutics changes reporting currency to US dollars

Login to your account

Quickpicks are a member only feature

Login to your account